[Effective gene therapy for neoplasms utilizing the prognostic factors].
Fujieda
Shigeharu
S
Sugimoto
Chizu
C
Ito
Toshihisa
T
Kimura
Yuichi
Y
Tsuzuki
Hideaki
H
Sunaga
Hiroshi
H
Seki
Mizue
M
Yamamoto
Hideyuki
H
Ikawa
Hideki
H
Saito
Hitoshi
H
D000818:Animals; D017209:Apoptosis; D001221:Aspartate Carbamoyltransferase / Q000235:genetics / Q000502:physiology; D002223:Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) / Q000235:genetics / Q000502:physiology; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy*; D002945:Cisplatin / Q000494:pharmacology / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004080:Dihydroorotase / Q000235:genetics / Q000502:physiology; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D051379:Mice; D009097:Multienzyme Complexes / Q000235:genetics / Q000502:physiology; D009959:Oropharyngeal Neoplasms / Q000473:pathology / Q000628:therapy*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein
C033626:CAD trifunctional enzyme; D009097:Multienzyme Complexes; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein; D001221:Aspartate Carbamoyltransferase; D004080:Dihydroorotase; D002223:Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); D002945:Cisplatin